Fig. 3From: The biology and role of CD44 in cancer progression: therapeutic implicationsCD44 promoter activity comparison among different treatment of cytokines groups. TGFβ, HGF, IL-6, IGF1, and EGF treated on CFPAC-1 CD44 low cells. TGFβ transforming growth factor β, HGF hepatocyte growth factor, IL-6 interleukin-6, IGF1 insulin-like growth factor 1, EGF epidermal growth factorBack to article page